InsiderClue
← All stocks

KIORA PHARMACEUTICALS INC

KPRX Net buying
CIK 0001372514 #5217 in the set updated 22 Sep 2026
Bought (120 mo)
$15.81M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$15.30M
$0.00 on a plan · $12.11M straight out of an exercise
Sold at will
$3.19M
23 of 28 sales
Net
+$506.27K
+$12.62M against sales at will

By person

19 insiders · 159 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
ARMISTICE CAPITAL, LLC entity
10% owner
$15.67M (111)
$15.19M (9) scheduled
+$472.88K
7,478,202
—
$27.52M
—
GOLDBERG MORTON
Director
—
$48.93K (3)
−$48.93K
0
0.0000%
$0.00
—
Strem Brian M.
President and CEO
$40.17K (2)
—
+$40.17K
58,823
1.33%
$216.47K
—
Parsons Erin
Director
$25.67K (1)
—
+$25.67K
5,260
0.1189%
$19.36K
—
TYLE PRAVEEN
Director
$19.80K (1)
—
+$19.80K
5,014
0.1133%
$18.45K
—
FROM STEPHEN
Executive Chairman
$12.88K (3)
$30.11K (3)
−$17.23K
67,693
1.53%
$249.11K
—
Ventech Capital II entity
10% owner
—
$12.38K (1)
−$12.38K
1,431,814
32.36%
$5.27M
−0.3%
Shapiro Aron
Director
$10.80K (1)
—
+$10.80K
3,000
0.0678%
$11.04K
—
Daniels Eric Joseph
Chief Development Officer
$7.57K (1)
—
+$7.57K
31,741
0.7174%
$116.81K
—
Tosca Melissa
CFO
$6.95K (2)
—
+$6.95K
26,064
0.5891%
$95.92K
—
Romano Sarah
Chief Financial Officer
$10.00K (3)
$4.67K (3)
+$5.33K
22,746
0.5141%
$83.71K
—
Walters-Hoffert Lisa
Director
$4.83K (1)
—
+$4.83K
1,250
0.0283%
$4.60K
—
MANZO MICHAEL P.
VP of Engineering
—
$4.67K (3)
−$4.67K
15,378
0.3476%
$56.59K
—
Wirostko Barbara
Chief Medical Officer
—
$4.60K (3)
−$4.60K
463,808
10.48%
$1.71M
+210.2%
Stengone Carmine N.
Director
$4.60K (1)
—
+$4.60K
1,250
0.0283%
$4.60K
—
Mann Brenda
VP of Research & Development
—
$4.50K (3)
−$4.50K
15,136
0.3421%
$55.70K
—
Garanzini Michael
Chief Commercial Officer
— (1)
—
$0.00
196,250
4.44%
$722.20K
—
CHANEY PAUL G
Director
—
—
—
91,229
2.06%
$335.72K
+285.6%
MALFROY-CAMINE BERNARD
Director
—
—
—
61,525
1.39%
$226.41K
+433.8%

Individual transactions

23
Insider
Date
Role
Action
Shares
Price
Amount
ARMISTICE CAPITAL, LLC
2 Aug 2021
10% owner
Sell indirect
192,775
$2.40
$463.05K
ARMISTICE CAPITAL, LLC
30 Jul 2021
10% owner
Sell indirect
68,188
$2.69
$183.56K
ARMISTICE CAPITAL, LLC
29 Jul 2021
Director
Sell indirect
400,000
$3.00
$1.20M
ARMISTICE CAPITAL, LLC
28 Jul 2021
Director
Sell indirect
375,443
$3.28
$1.23M
GOLDBERG MORTON
6 Dec 2019
Director
Sell
1,961
$6.93
$13.59K
GOLDBERG MORTON
12 Nov 2019
Director
Sell
2,001
$4.29
$8.58K
Mann Brenda
15 Jul 2019
VP of Research & Development
Sell
6,350
$0.23
$1.48K
FROM STEPHEN
15 Jul 2019
President and CEO
Sell
42,452
$0.23
$9.89K
Wirostko Barbara
15 Jul 2019
Chief Medical Officer
Sell
6,488
$0.23
$1.51K
MANZO MICHAEL P.
15 Jul 2019
VP of Engineering
Sell
6,584
$0.23
$1.53K
Romano Sarah
15 Jul 2019
Chief Financial Officer
Sell
6,584
$0.23
$1.53K
Mann Brenda
12 Jul 2019
VP of Research & Development
Sell
6,350
$0.24
$1.50K
FROM STEPHEN
12 Jul 2019
President and CEO
Sell
42,452
$0.24
$10.00K
Wirostko Barbara
12 Jul 2019
Chief Medical Officer
Sell
6,488
$0.24
$1.53K
MANZO MICHAEL P.
12 Jul 2019
VP of Engineering
Sell
6,583
$0.24
$1.55K
Romano Sarah
12 Jul 2019
Chief Financial Officer
Sell
6,583
$0.24
$1.55K
Mann Brenda
11 Jul 2019
VP of Research & Development
Sell
6,349
$0.24
$1.53K
FROM STEPHEN
11 Jul 2019
President and CEO
Sell
42,451
$0.24
$10.21K
Wirostko Barbara
11 Jul 2019
Chief Medical Officer
Sell
6,487
$0.24
$1.56K
MANZO MICHAEL P.
11 Jul 2019
VP of Engineering
Sell
6,583
$0.24
$1.58K
Romano Sarah
11 Jul 2019
Chief Financial Officer
Sell
6,583
$0.24
$1.58K
Ventech Capital II
13 Mar 2017
10% owner
Sell
4,419
$2.80
$12.38K
GOLDBERG MORTON
6 Mar 2017
Director
Sell
8,919
$3.00
$26.76K
Show all 159 transactions →

What was left out

Form 4 filings counted 296
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 5
Sales at will 23
Transactions with no price 5
Shares from compensation/vesting 3,253,681
Sales filed before the plan box existed 23
History held since 16 Sep 2016